Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00420550 · ClinicalTrials.gov registry record · Phase 2
Study of Biomarkers and the Relaxation Response Using Guided Imagery in Women With IC
A Phase 2 study of Interstitial Cystitis and Pelvic Pain, sponsored by Corewell Health East.
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT00420550 is a Phase 2 study of Interstitial Cystitis and Pelvic Pain that has completed, run by Corewell Health East. The registered enrollment target is 10 participants, below the 362-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00420550, a Phase 2 study of Interstitial Cystitis and Pelvic Pain, has completed, sponsored by Corewell Health East.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Interstitial cystitis (IC) affects more than one million women in the United States. It has been thought that IC patients who have been unable to obtain adequate relief from medical remedies would value a psychotherapeutic intervention that could diminish some of their pain. There are currently no studies using biomarkers with the use of a relaxation technique called guided imagery in IC patients. Many guided imagery intervention studies in areas such as cancer, post-operative pain, and arthritis reported that guided imagery resulted in improvements in the psychological or physiological outcomes examined. If this is also true in IC patients, this intervention may prevent the use of unnecessary medications and procedures that are currently being used.
Conditions Studied
Interventions
- BEHAVIORAL Relaxation Response using Guided Imagery
Study Locations (1)
Michigan
- William Beaumont Hospital - Royal Oak
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2007-01 |
| Est. Completion | 2007-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00420550
The ClinicalTrials.gov registry entry for NCT00420550 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 362-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (97% lower). The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Interstitial Cystitis appearing as the primary indexed condition, and to 1 intervention - of which Relaxation Response using Guided Imagery is the first listed.
NCT00420550 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT00420550 about?
NCT00420550 is a clinical study titled "Study of Biomarkers and the Relaxation Response Using Guided Imagery in Women With IC". Interstitial cystitis (IC) affects more than one million women in the United States. It has been thought that IC patients who have been unable to obtain adequate relief from medical remedies would value a psychotherapeutic intervention that could diminish some of their pain. There are currently no ...
What is the current status of trial NCT00420550?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2007-01. Estimated completion is 2007-12.
What conditions does trial NCT00420550 study?
This clinical trial studies the following conditions: Interstitial Cystitis, Pelvic Pain.
What interventions are being tested in trial NCT00420550?
The interventions under investigation include: Relaxation Response using Guided Imagery (BEHAVIORAL).
Who is sponsoring clinical trial NCT00420550?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00420550 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Interstitial Cystitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome
RECRUITING · Phase 2
-
Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS
RECRUITING · Phase 2
-
Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)
RECRUITING · Phase 2
-
Study of U101 for Bladder Pain and/or Urgency
COMPLETED · Phase 2
-
Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment
RECRUITING · NA
-
Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.